1217860-94-0
Chemical Structure
Danofloxacin-d3 mesylate
- CAS No.: 1217860-94-0
- Formula:C20H21D3FN3O6S
- Molecular Weight:456.50
IUPAC Name: 1-cyclopropyl-6-fluoro-7-((1S,4S)-5-(methyl-d3)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound with methanesulfonic acid (1:1)
InChIKey: APFDJSVKQNSTKF-MIJXDKMRSA-N
SMILES: CS(=O)(O)=O.O=C1C2=CC(F)=C(N3[C@H]4C[C@H](N(C4)C([2H])([2H])[2H])C3)C=C2N(C5CC5)C=C1C(O)=O
Biological Activity: Danofloxacin-d3 (mesylate) is the deuterium labeled Danofloxacin mesylate. Danofloxacin mesylate (CP 76136-27) is a fluoroquinolone antibacterial for veterinary use.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Danofloxacin-d3 mesylate | Danofloxacin-d3 (mesylate) is the deuterium labeled Danofloxacin mesylate. Danofloxacin mesylate (CP 76136-27) is a fluoroquinolone antibacterial for veterinary use. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Danofloxacin mesylate (Standard) | ≥98% | Danofloxacin mesylate (Standard) is the analytical standard of Danofloxacin mesylate. This product is intended for research and analytical applications. Danofloxacin mesylate (CP 76136-27) is a fluoroquinolone used as a veterinary drug. Danofloxacin mesylate has a broad spectrum of bactericidal activity, mainly inhibiting the DNA cycloenzyme of the bacteria. In addition, Danofloxacin mesylate is a substrate for ATP-dependent efflux transporters (P-gp and MRP2). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Danofloxacin mesylate | 99.88% | Danofloxacin mesylate (CP 76136-27) is a fluoroquinolone used as a veterinary drug. Danofloxacin mesylate has a broad spectrum of bactericidal activity, mainly inhibiting the DNA cycloenzyme of the bacteria. In addition, Danofloxacin mesylate is a substrate for ATP-dependent efflux transporters (P-gp and MRP2). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||